These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3756323)

  • 1. [Localization of binding sites in rat muscles and brain for cobra neurotoxin and serum immunoglobulins from patients with myasthenia].
    Smirnov VA; Vladeeva NV; Lobzin VS; Paniukov AN
    Biull Eksp Biol Med; 1986 Sep; 102(9):275-6. PubMed ID: 3756323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactions between 3H-monoacetylcobratoxin and membrane preparations from denervated muscles and caudate nuclei].
    Paniukov AN; Smirnov VA
    Biull Eksp Biol Med; 1980 May; 89(5):574-5. PubMed ID: 7397340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of myasthenia gravis.
    Heilbronn E; Stålberg E
    J Neurochem; 1978 Jul; 31(1):5-11. PubMed ID: 209148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production of antiserum to neurotoxin-2 from Naja naja oxiana cobra venom and reaction with the toxin].
    Bortnik AT; Rozanov SI
    Zh Evol Biokhim Fiziol; 1979; 15(5):543-5. PubMed ID: 92118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of modification of Naja naja oxiana neurotoxin II on the stoichiometry of its complexes with acetylcholine receptor].
    Karelin AA; Pluzhnikov KA; Tsetlin VI
    Bioorg Khim; 1986 Apr; 12(4):448-56. PubMed ID: 3718547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of the acetylcholine receptor binding site of a long-chain neurotoxin by toxin-specific monoclonal antibodies.
    Charpentier I; Pillet L; Karlsson E; Couderc J; Ménez A
    J Mol Recognit; 1990 Apr; 3(2):74-81. PubMed ID: 1694448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relative localization of the bound acetylcholine receptor subunits and neurotoxin].
    Tsetlin VI; Pluzhnikov KA; Karelin AA; Karlsson E; Ivanov VT
    Bioorg Khim; 1984 Feb; 10(2):176-87. PubMed ID: 6487390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer modeling of the neurotoxin binding site of acetylcholine receptor spanning residues 185 through 196.
    Garduno-Juarez R; Shibata M; Zielinski TJ; Rein R
    Acta Biochim Biophys Hung; 1987; 22(4):391-402. PubMed ID: 3132001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved method for the isolation, characterization and examination of neuromuscular and toxic properties of selected polypeptide fractions from the crude venom of the Taiwan cobra Naja naja atra.
    Ständker L; Harvey AL; Fürst S; Mathes I; Forssmann WG; Escalona de Motta G; Béress L
    Toxicon; 2012 Sep; 60(4):623-31. PubMed ID: 22677803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.
    Mittag T; Kornfeld P; Tormay A; Woo C
    N Engl J Med; 1976 Mar; 294(13):691-4. PubMed ID: 1250280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis.
    Xu K; Jha S; Hoch W; Dryer SE
    Neuroscience; 2006 Dec; 143(3):655-9. PubMed ID: 17081697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of 125I-toxin, from the spitting cobra Naja mossambica mossambica, at frog neuromuscular junctions.
    Tessier M; Grillo JM; Mambrini J
    Toxicon; 1978; 16(6):682-5. PubMed ID: 725961
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.
    Mittag TW; Tormay A; Massa T
    Mol Pharmacol; 1978 Jan; 14(1):60-8. PubMed ID: 625290
    [No Abstract]   [Full Text] [Related]  

  • 17. The pathophysiology of penicillamine-induced myasthenia gravis.
    Kuncl RW; Pestronk A; Drachman DB; Rechthand E
    Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 19. The biology of myasthenia gravis.
    Drachman DB
    Annu Rev Neurosci; 1981; 4():195-225. PubMed ID: 7013636
    [No Abstract]   [Full Text] [Related]  

  • 20. A computer modeling study of acetylcholine receptor-ligand interactions.
    Shibata M; Rein R
    Prog Clin Biol Res; 1989; 289():39-54. PubMed ID: 2726807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.